Correlation of hand-foot skin reaction (HFS) with treatment efficacy in pancreatic cancer (PC) patients (pts) treated with gemcitabine/capecitabine plus erlotinib: A subgroup analysis from the AIO-PK0104 randomized, cross-over phase III trial in advanced PC.

Authors

null

Michael Haas

Department of Hematology and Oncology, Klinikum Grosshadern and Comprehensive Cancer Center, LMU Munich, Munich, Germany

Michael Haas , Stefan Hubert Boeck , Ruediger Paul Laubender , Dominik Paul Modest , Ursula Vehling-Kaiser , Dirk Waldschmidt , Erika Kettner , Angela Maerten , Cornelia Winkelmann , Stefan Klein , Georgi Kojouharoff , Thomas C. Gauler , Ludwig Fischer Von Weikersthal , Michael Clemens , Michael Geissler , Tim F Greten , Susanna Hegewisch-Becker , Oleg Rubanov , Ulrich Robert Mansmann , Volker Heinemann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT00440167

Citation

J Clin Oncol 30, 2012 (suppl; abstr 4023)

DOI

10.1200/jco.2012.30.15_suppl.4023

Abstract #

4023

Poster Bd #

15

Abstract Disclosures

Similar Posters

First Author: Akira Shinohara

First Author: Stefan Boeck

First Author: Karyn A. Goodman